title: Microparticles as autoadjuvants in the pathogenesis of SLE.
abstract: Nucleic acids represent the main source of autoantigens in systemic lupus erythematosus (SLE). DNA and RNA can exit the cell during cell death and, in the extracellular space, can be immunostimulatory. Also extracellularly, DNA and RNA can be incorporated into microparticles (MPs)-small, membrane-bound vesicles released from dying cells by blebbing. We suggest that MPs display autoantigens, such as RNA and DNA, in a highly immunostimulatory manner, enabling them to function as autoadjuvants. In the bone marrow, nucleic-acid-containing MP autoadjuvants might induce B-cell tolerance, whereas in the periphery, they might stimulate mature B cells that have escaped central tolerance. Indeed, because MP autoadjuvants can trigger several receptors, they could effectively provide apoptotic or activating signals to B cells. We would therefore advance the idea that a model for SLE based on MP autoadjuvants can provide a new paradigm to elucidate the mechanisms by which DNA and RNA affect the immune system and critically influence B-cell fate.
authors.affiliation: Department of Medicine and Immunology, Duke University Medical Center, Medical Research Service, Durham VA Hospital, 151G Durham VAMC, 508 Fulton Street, Durham, NC 27705, USA. dpiset@acpub.duke.edu
authors.forename: David S
authors.initials: DS
authors.lastname: Pisetsky
authors.forename: Peter E
authors.initials: PE
authors.lastname: Lipsky
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D000974:Antibodies, Antinuclear / Q000276:immunology; D001324:Autoantigens / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology; D055252:Cell-Derived Microparticles / Q000276:immunology*; D004247:DNA / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000209:etiology / Q000276:immunology*; D012313:RNA / Q000276:immunology*; D051193:Toll-Like Receptors / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D000974:Antibodies, Antinuclear; D001324:Autoantigens; D051193:Toll-Like Receptors; D012313:RNA; D004247:DNA
references.citation: Nature. 2007 Oct 4;449(7162):564-9
references.pmid: 17873860
references.citation: Clin Chem. 2001 Aug;47(8):1488-9
references.pmid: 11468248
references.citation: Blood Rev. 2007 May;21(3):157-71
references.pmid: 17118501
references.citation: J Immunol. 2009 Sep 1;183(5):3109-17
references.pmid: 19648272
references.citation: Hum Mol Genet. 2009 Oct 15;18(R2):R130-6
references.pmid: 19808788
references.citation: Arthritis Rheum. 2007 Nov;56(11):3564-74
references.pmid: 17968936
references.citation: Eur J Immunol. 2009 Sep;39(9):2317-24
references.pmid: 19714572
references.citation: J Immunol. 2006 Nov 15;177(10):6573-8
references.pmid: 17082566
references.citation: Immunity. 2006 Sep;25(3):417-28
references.pmid: 16973389
references.citation: Exp Cell Res. 2000 Nov 1;260(2):248-56
references.pmid: 11035919
references.citation: Nature. 2009 Mar 26;458(7237):514-8
references.pmid: 19158675
references.citation: Nat Genet. 2000 Jun;25(2):177-81
references.pmid: 10835632
references.citation: Cell Immunol. 2004 May;229(1):31-40
references.pmid: 15331326
references.citation: Rheumatology (Oxford). 2005 Sep;44(9):1101-7
references.pmid: 15928001
references.citation: Nature. 1995 Apr 6;374(6522):546-9
references.pmid: 7700380
references.citation: Blood. 2009 Jan 1;113(1):214-23
references.pmid: 18824594
references.citation: Nat Rev Rheumatol. 2010 Jan;6(1):21-9
references.pmid: 19949432
references.citation: Immunity. 1996 Oct;5(4):303-10
references.pmid: 8885863
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10592-7
references.pmid: 12947040
references.citation: Arthritis Rheum. 2006 Mar;54(3):951-62
references.pmid: 16508978
references.citation: Arthritis Res Ther. 2008;10(5):218
references.pmid: 18947369
references.citation: Nature. 2009 Mar 26;458(7237):509-13
references.pmid: 19158676
references.citation: Nat Biotechnol. 2006 May;24(5):559-65
references.pmid: 16648842
references.citation: Immunol Res. 2009;43(1-3):98-108
references.pmid: 18810334
references.citation: J Exp Med. 2005 Mar 7;201(5):703-11
references.pmid: 15738055
references.citation: Exp Cell Res. 2009 Mar 10;315(5):760-8
references.pmid: 19146850
references.citation: J Immunol. 1999 Dec 1;163(11):6306-13
references.pmid: 10570325
references.citation: J Immunol. 2007 Jun 1;178(11):6876-85
references.pmid: 17513736
references.citation: J Immunol. 2010 Feb 15;184(4):1840-8
references.pmid: 20089701
references.citation: Immunol Rev. 2009 Nov;232(1):34-41
references.pmid: 19909354
references.citation: Blood. 2003 Sep 15;102(6):2243-50
references.pmid: 12775567
references.citation: J Immunol. 2009 Apr 1;182(7):4116-26
references.pmid: 19299709
references.citation: Nat Immunol. 2007 May;8(5):487-96
references.pmid: 17417641
references.citation: Cell Death Differ. 2008 Jan;15(1):183-91
references.pmid: 17932498
references.citation: Arthritis Rheum. 2005 May;52(5):1491-503
references.pmid: 15880830
references.citation: Curr Opin Immunol. 2006 Jun;18(3):286-91
references.pmid: 16616474
references.citation: Curr Opin Immunol. 2009 Jun;21(3):339-45
references.pmid: 19493664
references.citation: J Exp Med. 2004 Jun 21;199(12):1631-40
references.pmid: 15197227
references.citation: Blood. 2005 Sep 15;106(6):2200-5
references.pmid: 15933051
references.citation: Clin Chem. 2002 Aug;48(8):1212-7
references.pmid: 12142376
references.citation: PLoS One. 2009 Jun 02;4(6):e5776
references.pmid: 19488401
references.citation: Arthritis Rheum. 2006 Feb;54(2):408-20
references.pmid: 16447217
references.citation: Curr Dir Autoimmun. 2006;9:120-42
references.pmid: 16394658
references.citation: Mol Immunol. 2008 Apr;45(7):2038-44
references.pmid: 18031817
references.citation: Leukemia. 2006 Sep;20(9):1487-95
references.pmid: 16791265